Skip Navigation


QJM Advance Access originally published online on January 17, 2005
QJM 2005 98(2):113-118; doi:10.1093/qjmed/hci016
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
98/2/113    most recent
hci016v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dale, C.
Right arrow Articles by Henry, J.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dale, C.
Right arrow Articles by Henry, J.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

QJM vol. 98 no. 2 © Association of Physicians 2005; all rights reserved.

Assessment of a point-of-care test for paracetamol and salicylate in blood

C. Dale1, A.A.M. Aulaqi2, J. Baker3, R.C. Hobbs1, M.E.L. Tan1, C. Tovey4, I.A.L. Walker2 and J.A. Henry1

From the 1Academic Department of Accident and Emergency Medicine, Imperial College, London, 2Wexham Park Hospital, Slough, 3Charing Cross Hospital, London and 4Prince Charles Hospital, Merthyr Tydfil, UK

Received 12 December 2003 and in revised form 8 November 2004

Background: Paracetamol and salicylate are commonly taken in acute overdose. Clinicians have a low threshold for excluding the presence of these two drugs, by ordering laboratory tests in any patient suspected of ingesting an overdose or with an altered mental state.

Aim: To test the effectiveness of a new point of care test that qualitatively detects paracetamol and salicylate in blood and to examine the potential time saved by its use.

Design: Prospective multicentre trial.

Methods: The new test was compared with laboratory analysis in a routine blood sample taken from patients presenting to emergency departments with suspected overdose.

Results: The test had sensitivities of 98.5% and 88.5%, and specificities of 74.7% and 92%, for paracetamol and salicylate, respectively, at cut-off levels of 25 mg/l and 100 mg/l, respectively The point of care test results were available 2 h before the laboratory result.

Discussion: This point-of-care test could be used to rule out an overdose with either of these two drugs, and could thus lead to earlier clinical decisions for suspected overdose patients. Recommendations have been made following this trial that the cut-off value for paracetamol should be reduced from 25 mg/l to 12.5 mg/l in order to increase its usefulness. To prevent the test being misread, we also suggest that each device should be embossed to remind users that the presence of a line indicates there is no drug present.

Address correspondence to Dr C. Dale, Academic Department of Accident and Emergency Medicine, St Mary's Hospital, London W2 1NY. e-mail: christina.dale{at}imperial.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.